Development of a Novel Predictive-Prognostic Scoring Index for Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer

Background: Immune checkpoint inhibitors (ICIs) have become the standard of care for the treatment of patients with driver mutation absent advanced non-small cell lung cancer (NSCLC). The present study aimed to develop a reliable, reproducible, and practical scoring system to prognosticate and predi...

Descripción completa

Detalles Bibliográficos
Autores principales: Diker, Omer, Olgun, Polat, Balyemez, Ugurcan, Sigit Ikiz, Sinem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889841/
https://www.ncbi.nlm.nih.gov/pubmed/36733552
http://dx.doi.org/10.7759/cureus.33234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889841/
https://www.ncbi.nlm.nih.gov/pubmed/36733552
http://dx.doi.org/10.7759/cureus.33234

Ejemplares similares